- Home
- MGN vs MLSS Comparison
MGN vs MLSS Comparison
Compare MGN & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGN
- MLSS
- Stock Information
- Founded
- MGN 2020
- MLSS 1989
- Country
- MGN Malaysia
- MLSS United States
- Employees
- MGN N/A
- MLSS N/A
- Industry
- MGN
- MLSS Industrial Specialties
- Sector
- MGN
- MLSS Health Care
- Exchange
- MGN Nasdaq
- MLSS Nasdaq
- Market Cap
- MGN 43.0M
- MLSS 42.4M
- IPO Year
- MGN 2025
- MLSS 1995
- Fundamental
- Price
- MGN $1.50
- MLSS $0.37
- Analyst Decision
- MGN
- MLSS Buy
- Analyst Count
- MGN 0
- MLSS 1
- Target Price
- MGN N/A
- MLSS $1.25
- AVG Volume (30 Days)
- MGN 637.0K
- MLSS 3.0M
- Earning Date
- MGN 11-28-2025
- MLSS 11-13-2025
- Dividend Yield
- MGN N/A
- MLSS N/A
- EPS Growth
- MGN N/A
- MLSS N/A
- EPS
- MGN 0.07
- MLSS N/A
- Revenue
- MGN $13,484,571.00
- MLSS $8,929,517.00
- Revenue This Year
- MGN N/A
- MLSS $16.06
- Revenue Next Year
- MGN N/A
- MLSS $14.73
- P/E Ratio
- MGN $21.59
- MLSS N/A
- Revenue Growth
- MGN N/A
- MLSS 0.59
- 52 Week Low
- MGN $1.30
- MLSS $0.33
- 52 Week High
- MGN $8.63
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- MGN N/A
- MLSS 39.03
- Support Level
- MGN N/A
- MLSS $0.35
- Resistance Level
- MGN N/A
- MLSS $0.42
- Average True Range (ATR)
- MGN 0.00
- MLSS 0.05
- MACD
- MGN 0.00
- MLSS -0.00
- Stochastic Oscillator
- MGN 0.00
- MLSS 28.84
About MGN Megan Holdings Limited Ordinary Shares
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.